S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
Gas prices dip in NJ, around nation as cold weather returns
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
Gas prices dip in NJ, around nation as cold weather returns
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
Gas prices dip in NJ, around nation as cold weather returns
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
Gas prices dip in NJ, around nation as cold weather returns
NYSEARCA:PRME

Prime Medicine - PRME Stock Forecast, Price & News

$21.11
+1.11 (+5.55%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$19.73
▼
$21.48
50-Day Range
$15.85
▼
$21.11
52-Week Range
$14.52
▼
$21.73
Volume
439,993 shs
Average Volume
152,800 shs
Market Capitalization
$1.99 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.75
Receive PRME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter.

Receive PRME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer First Trust
Fund NameFirst Trust Heitman Global Prime Real Estate ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:PRME
Inception Date11/12/2015
Fund ManagerJerry Ehlinger, John White, Jacques Perdrix, Andreas Welter
Webwww.primemedicine.com
PhoneN/A

Fund Focus

Asset ClassReal Estate
BenchmarkNot Applicable
CategoryReal Estate
FocusReal Estate
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$1.03 million
Average Daily Volume$213.00
Discount/Premium3.91%

ETF Expenses

Management Fee0.95%
Other Expenses0.00%
Total Expenses0.95%
Fee Waiver0.00%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorBrown Brothers Harriman & Co.
AdvisorFirst Trust Advisors L.P.
CustodianBrown Brothers Harriman & Co.
DistributorFirst Trust Portfolios L.P.
Transfer AgentBrown Brothers Harriman & Co.
Trustee
Lead Market MakerCredit Suisse

Key Executives

  • Dr. Keith Michael Gottesdiener M.D. (Age 69)
    Pres, CEO, Sec. & Director
    Comp: $867.11k
  • Dr. Ann L. Lee Ph.D. (Age 61)
    Chief Technical Officer
    Comp: $171.19k
  • Dr. Jeremy S. Duffield M.D. (Age 55)
    Ph.D., Chief Scientific Officer
    Comp: $994.4k
  • Dr. Andrew Anzalone M.D. (Age 37)
    Ph.D., Co-Founder, Sr. Scientist II, Head of Prime Editing Platform & Head of Platform Devel.
  • Dr. David R. Liu Ph.D.
    Co-Founder & Chair of Scientific Advisory Board
  • Ms. Carman Alenson CPA (Age 58)
    M.B.A., Chief Accounting Officer & Interim CFO
  • Dr. Meredith Goldwasser (Age 52)
    Sr. VP of Strategy & Corp. Operations and Head of Strategy & Corp. Operations
  • Dr. Karen Brown J.D.
    Ph.D., Sr. VP of Intellectual Property & Legal Affairs
  • Ms. Niamh Alix
    Chief HR Officer
  • Mr. Richard Brudnick (Age 65)
    Chief Bus. Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













PRME Stock - Frequently Asked Questions

Should I buy or sell Prime Medicine stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prime Medicine in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PRME shares.
View PRME analyst ratings or view top-rated stocks.

What is Prime Medicine's stock price forecast for 2023?

4 brokers have issued 12 month target prices for Prime Medicine's stock. Their PRME share price forecasts range from $21.00 to $27.00. On average, they predict the company's stock price to reach $23.75 in the next twelve months. This suggests a possible upside of 12.5% from the stock's current price.
View analysts price targets for PRME or view top-rated stocks among Wall Street analysts.

How have PRME shares performed in 2023?

Prime Medicine's stock was trading at $18.58 at the start of the year. Since then, PRME stock has increased by 13.6% and is now trading at $21.11.
View the best growth stocks for 2023 here.

What is Prime Medicine's stock symbol?

Prime Medicine trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PRME."

When does the company's lock-up period expire?

Prime Medicine's lock-up period expires on Tuesday, April 18th. Prime Medicine had issued 10,294,118 shares in its public offering on October 20th. The total size of the offering was $175,000,006 based on an initial share price of $17.00. After the expiration of the company's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Who are Prime Medicine's major shareholders?

Prime Medicine's stock is owned by a variety of retail and institutional investors. Top institutional investors include ARK Investment Management LLC (1.74%), Sumitomo Mitsui Trust Holdings Inc. (0.52%), OUP Management Co. LLC (0.13%), Clarius Group LLC (0.02%), New York State Common Retirement Fund (0.01%) and Strs Ohio (0.00%). Insiders that own company stock include 2019 Gp LLC Gv and Thomas Cahill.
View institutional ownership trends.

How do I buy shares of Prime Medicine?

Shares of PRME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Prime Medicine's stock price today?

One share of PRME stock can currently be purchased for approximately $21.11.

How much money does Prime Medicine make?

Prime Medicine (NYSEARCA:PRME) has a market capitalization of $1.99 billion.

This page (NYSEARCA:PRME) was last updated on 2/5/2023 by MarketBeat.com Staff